Default Category
-
American Well: The Doctor Will E-See You Now
Ofek, Elie; Laufer, RonCase HBS-510061-EMarketingWhat is next for healthcare IT provider American Well, whose innovative Online Care technology allows physicians to deliver care to patients online in real time? Using American Well's platform, patients with non-emergency health concerns can communicate with physicians online or by phone and receive advice or even a diagnosis without having to visit the physician's office. American Well's co-founders, Ido Schoenberg and Roy Schoenberg, believe th...Starting at €8.20
-
The Development of the Markets for Natural, Organic, and Health Foods in the U.S., Module Note
Khaire, Mukti; Kenyon, EleanorCase HBS-815054-EMarketingDiscourses on the links between eating, health, and social standing in America have deep roots. As mechanisms of food production, distribution and storage were developed in the nineteenth century, Americans began receiving information about what to and not-to eat, from public and religious figures, scientists, government officials, and food companies. In an increasingly industrializing and urbanizing society, such information translated into cons...Starting at €8.20
-
The Doctor Will E-See You Now (Spanish version)
Ofek, Elie; Laufer, RonCase HBS-518S11MarketingWhat is next for healthcare IT provider American Well, whose innovative Online Care technology allows physicians to deliver care to patients online in real time? Using American Well's platform, patients with non-emergency health concerns can communicate with physicians online or by phone and receive advice or even a diagnosis without having to visit the physician's office. American Well's co-founders, Ido Schoenberg and Roy Schoenberg, believe th...Starting at €8.20
-
Eli Lilly: Developing Cymbalta
Ofek, Elie; Laufer, RonCase HBS-507044-EMarketingAnticipating the expiration of its Prozac patent, Eli Lilly has to make tough decisions regarding the development of its next-generation antidepressant drug. In particular, the company needs to decide whether to first establish that once-a-day dosing for Cymbalta (Duloxetine) is effective in treating major depressive disorder and only after launch get FDA approval for treating painful physical symptoms, or to first establish efficacy in treating ...Starting at €8.20